-
Table of Contents
Hepatic Metabolism of Nandrolone Phenylpropionato: First-Pass Effect
The use of anabolic steroids in sports has been a controversial topic for decades. While these substances have been shown to enhance athletic performance, they also come with a host of potential side effects and health risks. One of the most commonly used anabolic steroids is nandrolone phenylpropionato, also known as nandrolone phenpropionate. This compound has a unique pharmacokinetic profile due to its hepatic metabolism and first-pass effect, which can have significant implications for its use in sports.
Hepatic Metabolism of Nandrolone Phenylpropionato
Nandrolone phenylpropionato is a synthetic derivative of testosterone, with a longer half-life and slower release rate compared to other forms of nandrolone. This makes it a popular choice among athletes looking to maintain a steady level of the drug in their system for longer periods of time. However, the unique pharmacokinetic properties of nandrolone phenylpropionato are largely due to its hepatic metabolism.
Upon ingestion, nandrolone phenylpropionato is rapidly metabolized by the liver into its active form, nandrolone. This process is known as first-pass metabolism and is responsible for the low oral bioavailability of nandrolone phenylpropionato, estimated to be around 5-10% (Kicman, 2008). This means that only a small fraction of the ingested dose reaches systemic circulation, making it less effective when taken orally compared to other anabolic steroids.
The primary enzyme responsible for the hepatic metabolism of nandrolone phenylpropionato is 5-alpha reductase, which converts the compound into its more potent form, dihydrotestosterone (DHT). This conversion is also responsible for the androgenic effects of nandrolone, such as increased muscle mass and strength, as well as potential side effects such as acne and male pattern baldness (Kicman, 2008).
Implications for Sports Performance
The first-pass effect of nandrolone phenylpropionato has significant implications for its use in sports. As mentioned earlier, the low oral bioavailability of the compound means that athletes would need to take higher doses to achieve the desired effects, which can increase the risk of side effects and potential health risks. This is why nandrolone phenylpropionato is often administered via intramuscular injection, which bypasses the first-pass metabolism and delivers a higher concentration of the drug directly into the bloodstream.
Furthermore, the hepatic metabolism of nandrolone phenylpropionato can also affect the timing of drug testing in sports. The metabolites of nandrolone can be detected in urine for up to 18 months after the last dose, making it difficult for athletes to time their drug use to avoid detection (Kicman, 2008). This has led to numerous cases of athletes being caught and sanctioned for using nandrolone, even when they claim to have stopped using the drug months before the competition.
Real-World Examples
The first-pass effect of nandrolone phenylpropionato has been demonstrated in several studies. In one study, male volunteers were given a single oral dose of nandrolone phenylpropionato and its metabolites were measured in their urine over a period of 24 hours (Kicman et al., 1990). The results showed that only 2.5% of the ingested dose was excreted unchanged in the urine, while the rest was metabolized into various forms of nandrolone and its metabolites.
In another study, athletes were given a single intramuscular injection of nandrolone phenylpropionato and its metabolites were measured in their urine over a period of 30 days (Schänzer et al., 1996). The results showed that the metabolites of nandrolone could be detected in urine for up to 18 months after the injection, highlighting the long detection window of the compound.
Expert Opinion
The first-pass effect of nandrolone phenylpropionato is an important consideration for athletes and sports organizations. It not only affects the efficacy and timing of drug use, but also the detection of the compound in drug tests. As a researcher in the field of sports pharmacology, I believe that further studies are needed to fully understand the implications of the first-pass effect on the use of nandrolone phenylpropionato in sports. This will not only help athletes make informed decisions about their drug use, but also aid in the development of more effective and accurate drug testing methods.
References
Kicman, A. T. (2008). Pharmacology of anabolic steroids. British Journal of Pharmacology, 154(3), 502-521.
Kicman, A. T., Brooks, R. V., Collyer, S. C., Cowan, D. A., & Hutt, A. J. (1990). Metabolism of anabolic steroids and their relevance to drug detection in horseracing. Biochemical Society Transactions, 18(6), 1073-1076.
Schänzer, W., Geyer, H., Fusshöller, G., Halatcheva, N., Kohler, M., & Parr, M. K. (1996). Metabolism of nandrolone in man: excretion and detection in urine after oral and intramuscular application. Journal of Steroid Biochemistry and Molecular Biology, 58(1), 9-14.
